Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$1.86M Buy
41,035
+10,299
+34% +$455K 0.05% 298
2017
Q1
$1.31M Hold
30,736
0.04% 322
2016
Q4
$1.23M Buy
30,736
+14,588
+90% +$563K 0.04% 326
2016
Q3
$627K Hold
16,148
0.02% 518
2016
Q2
$559K Hold
16,148
0.02% 535
2016
Q1
$557K Hold
16,148
0.02% 541
2015
Q4
$625K Hold
16,148
0.02% 499
2015
Q3
$632K Hold
16,148
0.02% 500
2015
Q2
$615K Buy
16,148
+6,757
+72% +$237K 0.02% 516
2015
Q1
$310K Hold
9,391
0.01% 593
2014
Q4
$251K Hold
9,391
0.01% 631
2014
Q3
$228K Hold
9,391
﹤0.01% 615
2014
Q2
$238K Hold
9,391
0.01% 597
2014
Q1
$202K Hold
9,391
0.01% 595
2013
Q4
$210K Sell
9,391
-50,487
-84% -$1.11M 0.01% 576
2013
Q3
$1.24M Hold
59,878
0.05% 218
2013
Q2
$1.16M Buy
+59,878
New +$1.25M 0.04% 213

Other funds holding HOLX

Delta Lloyd's HOLX Position: Q2 2017 in Review

Delta Lloyd increased its Hologic (HOLX) stake by 34% in Q2 2017, buying an estimated $455K and bringing the position to 41,035 shares worth $1.86M. The position accounts for 0.05% of the portfolio, ranked #298.

Delta Lloyd first reported a position in HOLX in Q2 2013 and has held it in 17 quarters since. 505 funds tracked by Wall St. Rank hold HOLX as of Q2 2017.

  • Delta Lloyd held 41,035 shares of Hologic worth $1.86M as of Q2 2017.
  • Delta Lloyd bought 10,299 Hologic shares in Q2 2017, an estimated $455K.
  • Hologic made up 0.05% of Delta Lloyd's portfolio in Q2 2017, its #298 holding.
  • Delta Lloyd first reported a position in Hologic in Q2 2013 and has held it in 17 quarters since.
  • 505 funds tracked by Wall St. Rank held Hologic as of Q2 2017.

Based on Delta Lloyd's 13F filing for Q2 2017, filed 9 Aug 2017.